New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition
This research article, brought to MedChemNet users free by our sister journal Future Medicinal Chemistry, discusses neurogenic agents as potentially innovative new drugs for the treatment of Alzheimer’s disease.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.